nalbuphine HCl ER
TR02ext
Phase 3 small_molecule completed
Quick answer
nalbuphine HCl ER for Uremic Pruritus is a Phase 3 program (small_molecule) at Trevi Therapeutics with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Trevi Therapeutics
- Indication
- Uremic Pruritus
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed